I give IVHN a "tentative" buy. Last Friday, for some unknown reason, the stock went from $.60 a share to $3.40. I was able to sell my 1000 shares at $3.00, and needless to say, I was pleased with my profit. The real mystery, or blessing depending on your approach, is the lack of information. I bought back in at $1.10, and I am waiting for it to shoot up once again.
As far as ALLP, this is a no-brainer. Right now this stock is trading at $.20 a share. In reality it is probably worth around $.50 a share, and that is before any more good news. In early January it shot up after the announcement of Oxygent getting approved in the EU. Like most thinly traded stocks, the profits were taken out of the share price before the real impact of the news could have a lasting effect. When investors begin to realize what a gem this is, I have no doubt that the stock could trade at $10 a share within a year. This is not the type of stock that you have to jump on immediately, however, you should do some research and evaluate the stock. After you realize what I am taalking about, I suggest you jump on it. For those who take solace in institutional reports, I suggest the Argus Research report released earlier this year, entitled "A Healthy Future" where Argus ranked ALLP the TOP stock, when evaluating healthcare companies with both current profits and a plan for the future.